Keros Therapeutics (KROS)
(Delayed Data from NSDQ)
$45.06 USD
-0.31 (-0.68%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $44.93 -0.13 (-0.29%) 7:48 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -1.26 |
EPS Last Quarter | -1.25 |
Last EPS Surprise | -1.63% |
ABR | 1.00 |
Earnings ESP
|
-1.23% |
---|---|
Current Year | -4.78 |
Next Year | -5.16 |
EPS (TTM) | -5.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 30.00M | 6.12M | 62.52M |
# of Estimates | NA | 1 | 5 | 1 |
High Estimate | NA | 30.00M | 30.12M | 62.52M |
Low Estimate | NA | 30.00M | 0.10M | 62.52M |
Year ago Sales | 0.01M | 0.14M | 0.15M | 6.12M |
Year over Year Growth Est. | NA | 21,328.57% | 3,950.60% | 922.24% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.26 | -1.07 | -4.78 | -5.16 |
# of Estimates | 8 | 6 | 8 | 8 |
Most Recent Consensus | -1.37 | -1.00 | -4.82 | -4.51 |
High Estimate | -1.11 | -0.71 | -4.29 | -4.44 |
Low Estimate | -1.47 | -1.28 | -5.30 | -6.39 |
Year ago EPS | -1.33 | -1.34 | -5.20 | -4.78 |
Year over Year Growth Est. | 5.26% | 20.15% | 8.08% | -7.90% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 3 | 3 | 4 |
Up Last 60 Days | 2 | 3 | 3 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 2 | 4 | 4 |
Down Last 60 Days | 3 | 2 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.26 | -1.07 | -4.78 | -5.16 |
7 Days Ago | -1.26 | -1.07 | -4.78 | -5.16 |
30 Days Ago | -1.22 | -1.09 | -4.80 | -5.13 |
60 Days Ago | -1.22 | -1.09 | -4.80 | -5.13 |
90 Days Ago | -1.23 | -1.13 | -4.83 | -5.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.27 | -1.06 | -4.81 | -5.16 |
Zacks Consensus Estimate | -1.26 | -1.07 | -4.78 | -5.16 |
Earnings ESP | -1.23% | 0.56% | -0.66% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.25 | -1.21 | -1.34 | -1.33 | NA |
Estimate | -1.23 | -1.31 | -1.38 | -1.34 | NA |
Difference | -0.02 | 0.10 | 0.04 | 0.01 | 0.03 |
Surprise | -1.63% | 7.63% | 2.90% | 0.75% | 2.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more